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Transplant glomerulopathy is an important cause of late graft
loss. Inflammatory lesions including glomerulitis and
peritubular capillaritis, suggestive of endothelial injury, are
prominent in this condition but the mechanism underlying
this inflammation remains unclear. Here we measured the
expression of T-bet (a member of the T-box family of
transcription factors regulating Th1 lineage commitment)
and its relationship with inflammation in 70 patients with
transplant glomerulopathy. Within this cohort, 32 patients
were diagnosed with transplant glomerulopathy, 23 with
interstitial fibrosis/tubular atrophy, and 15 with stable grafts.
There was a significant increase in T-bet expression in both
glomerular and peritubular capillaries of the transplant
glomerulopathy group. This expression was strongly
correlated with CD4þ , CD8þ , and CD68þ cell infiltration
within glomerular and peritubular capillaries. The expression
of GATA3, a Th2 regulator, was rarely found in the transplant
glomerulopathy group. Transplant glomerulopathy was
associated with diffuse peritubular capillary dilation without
reduced capillary density. Moreover, the degree of capillary
dilation was significantly correlated with the number of
infiltrating CD68þ cells. Since endothelial injury is a typical
lesion that follows alloantibody reactivity, our results suggest
that T-bet is involved in the pathogenesis of this
glomerulopathy.
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With the advent of novel immunosuppressive drugs, graft loss
due to early acute rejection has been greatly reduced.1 However,
the incidence of late graft loss remains unacceptably high.2 A
recent study suggested that the majority of late graft losses are
related to antibody-mediated rejection (AMR).3 Furthermore,
earlier reports showed that late graft loss always has a previous
emergence of anti-donor antibodies4 and that late AMR is
usually associated with poor graft survival.5,6 Clearly, AMR is
one of the most important causes of late graft loss.
Transplant glomerulopathy (TG) is a principal form of late
AMR.7,8 The incidence of TG is B20% by 5 years post
transplantation.9,10 TG is characterized by proteinuria, hyper-
tension, and declining graft function and is often associated
with the presence of donor-specific antibodies and positive
peritubular capillary (PTC) C4d deposition.9 Once TG has
been diagnosed, the likelihood of graft survival is extremely
poor.7,11 Recent studies showed a predominance of glomerulitis
and peritubular capillaritis (PTCitis) in TG.11,12 Glomerulitis
and PTCitis, both of which are forms of microcirculating
inflammation, are common features of both acute and chronic
AMR.13 Although microcirculating inflammation is generally
regarded to be a consequence of antibody reactivity, its
mechanism remains poorly understood.
T-bet, a member of the T-box family of transcription
factors, is a key regulator of Th1 lineage commitment and is
required for the optimal production of interferon-g.14,15 In
addition to its expression in CD4þ T cells, T-bet is also
expressed in other immune cells, including CD8þ T cells,16
B cells,17 dendritic cells,18 and natural killer cells.19 T-bet
overexpression was initially reported to be correlated with
acute cellular rejection at the level of transcription.20 Recently,
increased intragraft T-bet expression was observed in both late
AMR21 and TG.22 Our previous study23 revealed that T-bet
expression was typically located in glomerular capillary loops
and PTCs in AMR. Moreover, the predominant intraglomer-
ular expression of the transcription factor T-bet was found to
correlate strongly with the infiltration of intraglomerular
monocytes,23 which is a typical lesion of microcirculating
inflammation. The aforementioned data suggest that T-bet is
probably the key to clarifying the pathogenesis of micro-
circulating inflammation. As microcirculating inflammation
is common in TG, we postulate that T-bet is involved in the
pathogenesis of TG. Our data provide novel insight into the
development of antibody-mediated graft injury.
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RESULTS
Baseline patient characteristics
From January 2005 through December 2010, 462 renal
allograft recipients received renal allograft biopsies in Jinling
Hospital, Nanjing University School of Medicine. Among
these patients, 70 renal allograft recipients participated in this
study, including 32 cases of TG, 23 cases of interstitial
fibrosis/tubular atrophy (IF/TA), and 15 cases of stable grafts
as controls. The enrollment process of the patients is shown
in Supplementary Figure S1 online. The baseline patient
characteristics are listed in Table 1. None of the recipients had
previously received an organ transplant. There were no
significant differences between the three groups with respect
to patient age, gender, times of prior transplantation, or
incidence of positive panel–reactive antibody; however,
the stable graft group had a lower incidence of proteinuria
and an earlier biopsy time. The time of biopsy was similar
between the IF/TA and TG groups. Each patient received
anti-IL-2 receptor monoclonal antibody for the induction
of immunosuppressive therapy and was subsequently
maintained on a similar immunosuppressive protocol after
transplantation (Table 1).
TG is associated with microcirculating inflammation
On the basis of histological findings, the TG group had a
high prevalence of microcirculating inflammation; accord-
ing to the Banff 05 diagnostic criteria,8 93.8% of the patients
in the TG group had glomerulitis and 90.6% had PTC
inflammation, both of which were significantly higher than
the other two groups (Table 2). Microcirculating inflamma-
tion was observed in only a few of the recipients with stable
graft function, but was more common in the IF/TA group,
with glomerulitis occurring in 20 and 69.6% of the stable
graft and IF/TA group, respectively (P¼ 0.021; Table 2). The
patients in the TG group also had a higher incidence of
tubulitis (68.8% vs. 33.3% and 26.1% for the IF/TA and
stable graft groups, respectively, P¼ 0.090, P¼ 0.008),
intimal arteritis (59.4% vs. 0.0% and 4.3%, respectively,
Po0.001), and C4d deposition (75.0% vs. 6.7% and 0.0%,
respectively, Po0.001; Table 2). In the TG and IF/TA
groups, the incidences and degrees of tubular atrophy
(93.8% vs. 100%, respectively, P¼ 1.000) and interstitial
fibrosis (90.6% vs. 100%, respectively, P¼ 1.000) were
similar, whereas these lesions were not observed in the
stable graft group (Tables 2–4).
Table 1 | Clinical characteristics of patients participating in this study
Characteristics TG (n=32) Stable graft (n=15) IF/TA (n=23)
Gender, male (%) 24 (75.00) 11 (73.33) 15 (65.22)
Age (years) 43.56±11.16 42.93±14.46 42.48±10.09
Donor age (years) 37.13±10.22 39.00±6.80 40.17±7.36
Positive pre-transplant PRA (n) 0 0 0
Previous transplant 0 0 0
Previous rejection, n (%) 5 (15.63) 0 (0.00) 1 (4.35)
Cold ischemic time (h) 8.33±1.80 8.43±1.40 7.78±1.69
Warm ischemic time (min) 5.79±1.52 5.84±1.33 6.22±1.35
Induction with IL-2R antibody, n (%) 32 (100) 15 (100) 23 (100)
Baseline immunosuppressants
MMF+Tac+Pred 14 8 8
MMF+CsA+Pred 15 4 13
Others 3 3 2
Time of biopsy, median (range) 4.0 (1–11) years 9.07 (0–21) days 4.26 (1–11) years
Proteinuria, n (%) 29 (90.63)* 1 (6.67) 16 (69.57)*
Abbreviations: CsA, cyclosporine A; IF/TA, interstitial fibrosis/tubular atrophy; MMF, mycophenolate mofetil; Pred, prednisolone; PRA, panel-reactive antibody; Tac, tacrolimus;
TG, transplant glomerulopathy.
Categorical variables were compared by using Fisher’s exact test, continuous variables were compared using one-way analysis of variance. *Po0.001 vs. stable graft group.
Proteinuria was defined as urine protein 40.4 g/24 h.
Table 2 | Histological characteristics in the different groups
Post hoc
TG (n=32) Stable graft (n=15) IF/TA (n=23) P12 P13 P23
PTC inflammation, n (%) 29 (90.6) 1 (6.7) 4 (17.4) o0.001 o0.001 1.000
Glomerulitis, n (%) 30 (93.8) 3 (20.0) 16 (69.6) o0.001 0.078 0.021
Tubulitis, n (%) 22 (68.8) 5 (33.3) 6 (26.1) 0.090 0.008 1.000
Intimal arteritis, n (%) 19 (59.4) 0 (0.0) 1 (4.3) o0.001 o0.001 1.000
Interstitial fibrosis, n (%) 29 (90.6) 0 (0) 23 (100) o0.001 1.000 o0.001
Tubular atrophy, n (%) 30 (93.8) 0 (0) 23 (100) o0.001 1.000 o0.001
C4d, n (%) 24 (75.0) 1 (6.7) 0 (0) o0.001 1.000 1.000
Abbreviations: IF/TA, interstitial fibrosis/tubular atrophy; PTC, peritubular capillary; TG, transplant glomerulopathy.
Pairwise comparisons were done by Fisher’s exact test with Bonferroni correction for P value, where P12 means the adjusted P value for TG group and stable graft group, P13
means the adjusted P value for TG group and IF/TA group, P23 means the adjusted P value for stable graft group and IF/TA group.
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Microcirculating inflammation is correlated with T-bet
expression
In the TG group, we detected a significant increase in T-bet
expression in both the PTCs and the capillary loops of the
glomeruli, and this result was typically located within the
capillary lumen (Figure 1). According to the results of double
staining of T-bet and CD4þ /CD8þ , T-bet expression was
detected in a portion of CD4þ and CD8þ (Supplementary
Figure S2A and B online) cells and was strongly correlated
with intraglomerular and PTC CD4þ cell counts (r¼ 0.943,
Po0.001; r¼ 0.906, Po0.001, respectively) and CD8þ cell
counts (r¼ 0.936, Po0.001; r¼ 0.895, Po0.001, respectively,
Figure 2). Double staining of T-bet and CD68 did not show
T-bet expression in CD68þ cells (Supplementary Figure S2C
online); however, in situ T-bet expression was strongly
correlated with the number of CD68þ cells in both the
glomeruli (r¼ 0.579, P¼ 0.001) and the PTCs (r¼ 0.752,
Po0.001; Figure 2). We also performed GATA3 staining in
this group and detected GATA3 expression in the tubular cells
and in some of the T cells; however, both intra-PTC and
intraglomerular GATA3 expressions were rare (Supplemen-
tary Figure S3 online). We found no correlation between
GATA3 expression and microcirculating inflammation.
Intracapillary T-bet expression was also detected in the IF/
TA group; however, its expression was much lower than that in
the TG group (Po0.001, respectively). Moreover, T-bet
expression was observed primarily in the grafts that had
microcirculating inflammation. Similarly, T-bet was expressed
in a portion of CD4þ and CD8þ cells but not in CD68þ
cells, and the counts of CD4þ , CD8þ , and CD68þ cells
were all strongly correlated with the in situ expression of T-bet
both in glomeruli and in the PTC area. There were low and
nonexistent levels of T-bet and GATA3 expression, respectively,
in both the PTCs and glomeruli in the stable graft group.
TG is associated with capillary dilation
Labeling the endothelial cells for CD31 made it possible to
calculate the number and diameters of the capillaries. We
compared the PTC density and capillary diameter among the
three groups. In the IF/TA group, the density of PTCs was
significantly lower compared with the stable graft group
(18.14±2.90 vs. 24.40±1.72, respectively Po0.001), whereas
the diameter of the existing PTCs was larger (2.43±0.62 vs.
1.07±0.29, respectively, Po0.001), suggesting a rarefaction
and dilation of the capillaries (Figure 3). However, in the TG
group, we found no such rarefaction of PTCs as observed in
the IF/TA group. The capillary density was similar between the
TG group and protocol biopsies (23.87±3.92 vs. 24.40±1.72,
respectively, P¼ 1.000). However, the capillary diameter in the
TG group (6.35±2.15) was significantly higher than both the
protocol biopsy group (1.07±0.29, Po0.001) and the IF/TA
group (2.43±0.62, Po0.001). In addition, Image-Pro Plus
revealed a significantly larger intra-PTC area in the TG group
(0.09±0.03) compared with the IF/TA (0.03±0.01, Po0.001)
and stable graft (0.02±0.01, Po0.001) groups.
In addition to PTCs, capillary dilation was also observed
within the glomeruli. The diameter of the intraglomerular
capillaries in the TG group was significantly larger than in the
IF/TA and stable graft groups (Figure 3). Moreover, the
diameter of the glomeruli and intraglomerular area were both
significantly larger in the TG group than in the other two
groups (Figure 3).
Capillary dilation is correlated with microcirculating
inflammation
Co-staining of CD31 made it possible to explore easily the
nature of intracapillary inflammation. Figures 3a–d shows
Table 3 | Banff score of histological characteristics in the
different groups
Post hoc
Score
TG
(n=32)
Stable graft
(n=15)
IF/TA
(n=23) P12 P13 P23
PTC o0.001 o0.001 1.000
0 3 (9.4%) 14 (93.3%) 19 (82.6%)
1 10 (31.2%) 1 (6.7%) 4 (17.4%)
2 18 (56.3%) 0 0
3 1 (3.1%) 0 0
Glomerulitis o0.001 o0.001 0.007
0 2 (6.3%) 12 (80.0%) 7 (30.4%)
1 12 (37.5%) 3 (20.0%) 13 (56.6%)
2 14 (43.7%) 0 3 (13.0%)
3 4 (12.5%) 0 0
Tubulitis 0.037 0.003 1.000
0 10 (31.2%) 10 (66.7%) 17 (73.9%)
1 16 (50.0%) 5 (33.3%) 6 (26.1%)
2 6 (18.8%) 0 0
3 0 0 0
Intimal
arteritis
o0.001 o0.001 1.000
0 13 (40.6%) 15 (100%) 22 (95.7%)
1 18 (56.3%) 0 1 (4.3%)
2 1 (3.1%) 0 0
3 0 0 0
Interstitial
fibrosis
o0.001 0.544 o0.001
0 3 (9.4%) 15 (100%) 0
1 12 (37.5%) 0 7 (30.4%)
2 12 (37.5%) 0 11 (47.9%)
3 5 (15.6%) 0 5 (21.7%)
Tubular
atrophy
o0.001 1.000 o0.001
0 2 (6.3%) 15 (100%) 0
1 13 (40.6%) 0 9 (39.1%)
2 13 (40.6%) 0 11 (47.9%)
3 4 (12.5%) 0 3 (13.0%)
C4d o0.001 o0.001 0.647
0 8 (25.0%) 14 (93.3%) 23 (100%)
1 1 (3.1%) 1 (6.6%) 0
2 10 (31.3%) 0 0
3 13 (40.6%) 0 0
Abbreviations: IF/TA, interstitial fibrosis/tubular atrophy; PTC, peritubular capillary;
TG, transplant glomerulopathy.
Pairwise comparisons were done by Wilcoxon rank-sum test with Bonferroni
correction for P value, where P12 means the adjusted P value for TG group and stable
graft group, P13 means the adjusted P value for TG group and IF/TA group, P23
means the adjusted P value for stable graft group and IF/TA group.
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that CD31 staining labeled the capillaries notably well. In the
TG group, the infiltrating cells in both the glomeruli and
PTCs were primarily constituted of CD68þ , CD4þ , and
CD8þ cells, whereas no CD20þ cells were observed. The
dilation of PTCs was strongly correlated with the quantity of
infiltrating CD68þ cells (r¼ 0.523, P¼ 0.002) as shown in
Figure 3g. In contrast, capillary dilation was rarely observed
in areas that lacked PTCitis. We also calculated the ratio of
the total intra-PTC area within the cortex to the area of the
entire cortex and found that this ratio was also strongly
correlated with intra-PTC CD68þ cell counting (r¼ 0.561,
P¼ 0.001). However, in the IF/TA group, although there was
also a slight enlargement of PTCs, we found no correlation
with the degree of microcirculating inflammation.
Moreover, co-staining of CD31 and CD68 revealed that
the majority of the intraglomerular CD68þ cells were
located within the capillary loops. Similarly, the diameter of
the capillary loops was strongly correlated with the number
of intraglomerular CD68þ cells (r¼ 0.410, P¼ 0.022). In
contrast, in the IF/TA group, although glomerulitis with
CD68þ cells was common (being present in 69.6% of the
cohort), the majority of these cells were located outside of the
capillaries (Figure 3c).
Graft outcome. With respect to the outcome of the
allografts, the TG group had a poorer graft outcome than the
IF/TA group, with 1-year graft survival rates of 87.5 and
95.7%, respectively, and median survival times of 29 and 36
months, respectively. However, there was no statistical
significance between the two groups, and we found no
correlation between T-bet expression and graft outcome in
the present study. This finding may have been due to
insufficient power to detect a significant difference, as the
sample size was relatively small.
DISCUSSION
Microcirculating injury is a key lesion in the pathogenesis
of antibody-mediated allograft damage. To the best of our
knowledge, this study is the first to demonstrate that
microcirculating inflammation (including both glomerulitis
and PTC inflammation) is strongly correlated with in situ
T-bet expression. Our data also revealed that a unique
capillary dilation differs between the TG vs. the IF/TA and
stable graft groups, and that the degree of dilation is strongly
correlated with the degree of microcirculating inflammation.
Because microcirculating inflammation typically follows
alloantibody reactivity, these results shed new light to the
pathogenesis of TG.
Microcirculating inflammation is generally regarded to be
a lesion that is related to allo-antibody reactivity.3 Recently, a
high prevalence of microcirculating inflammation in patients
with TG was reported. However, our study revealed an even
higher incidence of microcirculating inflammation, as nearly
all of the patients in our TG group had microcirculating
inflammation. This is partially because all of the biopsies in
the TG group were index biopsies, which might reflect active
TG. These findings support the hypothesis that TG is
mediated by anti-donor antibodies.8 Clearly, microcirculating
inflammation is a key lesion in antibody-mediated graft
injury.3 Thus, it is of great importance to clarify the
pathogenesis of microcirculating inflammation. Although
glomerulitis was also noted in more than half of the IF/TA
patients, the location of their cellular infiltration was notably
different from that in the TG patients; specifically, in the TG
group, most of the infiltrating cells were located within the
capillary lumen, whereas in the IF/TA patients the infiltrating
cells were primarily scattered outside of the capillaries.
Our data show that the infiltration of intraglomerular and
PTC macrophages is strongly correlated with in situ over-
expression of the transcription factor T-bet. This correlation
is unique to the TG group, as the IF/TA and protocol biopsy
groups, which rarely have microcirculating inflammation,
only rarely exhibited T-bet expression in the glomeruli or
PTC areas. However, in TG cases, the degree of PTC
inflammation is consistent with the level of T-bet expression,
Table 4 | Immunohistological analysis of microcirculating inflammation
Post-hoc
TG (n=32) Stable graft (n=15) IF/TA (n=23) P12 P13 P23
PTC
T-bet 0.20 (0.16–0.30) 0.00 (0.00–0.04) 0.00 (0.00–0.10) o0.001 o0.001 1.000
GATA3 0.00 (0.00–0.02) 0.00 (0.00–0.00) 0.00 (0.00–0.00) 0.022 0.819 1.000
CD4 0.14 (0.10–0.18) 0.00 (0.00–0.04) 0.00 (0.00–0.12) o0.001 o0.001 1.000
CD8 0.21 (0.16–0.30) 0.00 (0.00–0.04) 0.00 (0.00–0.014) o0.001 o0.001 1.000
CD68 0.36 (0.23–0.51) 0.00 (0.00–0.04) 0.00 (0.00–0.25) o0.001 o0.001 1.000
GC
T-bet 1.50 (0.85–2.00) 0.00 (0.00–0.00) 0.00 (0.00–0.40) o0.001 o0.001 1.000
GATA3 0.00 (0.00–0.20) 0.00 (0.00–0.00) 0.00 (0.00–0.00) 0.075 0.392 1.000
CD4 1.00 (0.50–1.20) 0.00 (0.00–0.00) 0.20 (0.00–0.50) o0.001 o0.001 1.000
CD8 1.00 (0.73–1.50) 0.00 (0.00–0.00) 0.20 (0.00–0.60) o0.001 o0.001 1.000
CD68 7.18 (3.78–10.50) 0.00 (0.00–0.60) 0.80 (0.00–1.20) o0.001 o0.001 1.000
Abbreviations: GC, glomerular capillary; IF/TA, tubular atrophy/interstitial fibrosis; PTC, peritubular capillary; TG, transplant glomerulopathy.
All continuous variables were not normally distributed and thus were presented as median (25th–75th percentiles), and pairwise comparisons were done by Wilcoxon rank-
sum test with Bonferroni correction for P value, where P12 means the adjusted P value for TG group and stable graft group, P13 means the adjusted P value for TG group and
IF/TA group, P23 means the adjusted P value for stable graft group and IF/TA group.
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which means that the more the number of infiltration cells
that were observed, the higher the T-bet expression that was
detected. This finding suggests that T-bet expression might
account for the development of microcirculating inflamma-
tion. It will be interesting to determine whether T-bet
expression emerges before macrophage infiltration, and
whether sequential biopsies may be helpful for addressing
this question.
In renal transplantation, T-bet expression is increased in
acute cellar rejection (ACR),20 late AMR,21 and TG;22
however, its significance remains unclear. Our previous
study23 showed, for the first time, that T-bet expression is
correlated with intraglomerular inflammation in antibody-
mediated acute rejection. The present study shows that this
correlation also exists in TG, which is a chronic form of
AMR. Nevertheless, this study also revealed a strong
correlation between in situ T-bet expression and PTCitis, as
severe PTCitis was associated with high levels of in situ T-bet
expression, as we had expected. As controls, T-bet expression
was rarely observed in the grafts in the IF/TA and protocol
biopsy groups. These data suggest that PTCitis and glomeru-
litis share a common mechanism that is correlated with T-bet
expression and suggest that this mechanism is involved in
both the acute and chronic patterns of humoral rejection.
It is easy to understand that T-bet expression is correlated
with CD4þ and CD8þ cells, as T-bet can be expressed in
these cells. However, although CD68þ cells do not express
T-bet, the intra-PTC CD68þ count was strongly correlated
with in situ T-bet expression. As CD68þ monocytes are the
primary cells that cause PTCitis,13 these findings suggest that
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Figure 1 | Immunohistological analysis of intragraft T-bet and GATA3 expression in renal allografts with transplant glomerulopathy
(TG). Positive staining is labeled in brown. (a) Intraglomerular T-bet expression in TG (arrow). (b) T-bet expression within the peritubular
capillary (PTC) area in TG (arrow). (c) Intraglomerular T-bet expression in interstitial fibrosis/tubular atrophy (IF/TA). (d) T-bet expression
within the PTC area in IF/TA. (e) Intraglomerular T-bet expression in protocol biopsies (negative in this case). (f) T-bet expression within the
PTC area in protocol biopsies. (g) Quantitative measurement of the number of intraglomerular T bet–expressing cells in the TG, IF/TA
and stable graft (SG) groups. (h) Quantitative measurement of the number of T bet–expressing cells within the PTC in the three groups.
T-bet expression was positive in both the intraglomerular and PTC areas in the TG group, and was negative in both the IF/TA and SG groups.
(a–f) Original magnification,  400.
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T-bet upregulation may account for the pathogenesis of PTC
inflammation. On the contrary, although there was a slight
increase in the level of intracapillary GATA3 expression, its
level was much lower than T-bet expression. Recent studies
have demonstrated that the differentiation of naive Th cells to
a Th1 or Th2 phenotype is regulated by the transcription
factors T-bet and GATA3, respectively.24 Upstream T-bet
expression is usually correlated with the activity of Th1
function and the inhibition of Th2 activity,24 and this may
explain why T-bet expression is high and GATA3 expression
is low in the TG group. It is difficult to clarify the exact role
of T-bet in the pathogenesis of clinical microcirculating
inflammation; we hypothesize that T-bet expression can
promote the production of interferon-g, which in turn
stimulates the classical activation of macrophages. If so, the
macrophages enrolled in TG would mainly be of M1 type.
This hypothesis can be proved in animal models.
Our previous study suggested that the level of T-bet
expression in the glomeruli can distinguish AMR from
ACR.23 In this study, we found that T-bet expression also
distinguishes TG from IF/TA and stable grafts. Because the
sensitivity of measuring C4d in the diagnosis of AMR was
recently called into question,25,26 it is possible that intracap-
illary T-bet expression can be used as an additional marker of
antibody-mediated lesions.
Another interesting finding from this study is the unique
capillary dilation observed in the TG group. PTC dilation had
been observed in patients with AMR;9,27 however, its
significance and pathogenesis remain poorly understood.
We found that this capillary variation is different in various
forms of renal dysfunction. In chronic kidney disease, PTC
rarefaction, which is presumed to be associated with chronic
tubulointerstitial injury, is common. In renal allograft
recipients, rarefaction of PTCs has also been reported in
transplant nephrectomies, and this result was accompanied
by a compensatory enlargement in the capillary lumens.28 In
our study, we found a similar variation in the IF/TA group,
which had significantly decreased PTC density compared
with the normal controls. However, our results revealed a
strikingly different variation in the TG group: namely, there
was no decrease in the number of PTCs. Moreover, as
previously noticed,27 there was a significant enlargement in
the PTC lumen such that the calculated PTC area in the TG
group was nearly four times that of the stable graft and IF/TA
groups. Although capillary enlargement was also observed in
the IF/TA group, the extent of this enlargement was far from
comparable to the TG group. More interestingly, the dilation
of the PTC lumen was strongly correlated with the degree of
microcirculating inflammation, whereas PTC dilation was
only rarely observed in areas that lacked PTC inflammation.
This finding demonstrates a strong correlation between
capillary dilation and PTC cellular infiltration, and it is quite
likely that the capillary dilation is caused by in situ
inflammation. The mechanism for this phenomenon war-
rants further investigation.
Our previous study revealed that the level of T-bet
expression is correlated with the resistance to acute rejection
by steroid treatment,23 whereas other evidence suggested that
CD68þ cells are correlated with poor graft survival.29
Because T-bet expression is strongly correlated with CD68þ
cell infiltration, we hypothesized that T-bet expression is also
correlated with graft outcome. However, we found no
association between the level of intracapillary T-bet expres-
sion and graft survival. Given that the sample size was
relatively small in the present study, additional studies need
to be conducted to support this hypothesis.
In summary, this study shows that microcirculating
inflammation is strongly correlated with in situ T-bet
expression, whereas capillary dilation is strongly correlated
with the degree of microcirculating inflammation. These
results suggest that T-bet is associated with the development
of TG, and warrant further investigation.
MATERIALS AND METHODS
Patient selection
The patients were retrospectively selected from among 462 renal
allograft recipients who had performed renal allograft biopsies from
January 2005 through December 2010 in Jinling Hospital, Nanjing
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Figure 2 | The relationship between microcirculating
inflammation and in situ T-bet expression. In the transplant
glomerulopathy group, T-bet expression was strongly correlated
with the number of intraglomerular (a, c and e) and peritubular
capillary (PTC; b, d and f), CD4þ (a, b), CD8þ (c, d), and CD68þ
(e, f) cells.
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University School of Medicine, Nanjing, China. All were deceased
donors after cardiac death. We applied the following inclusion
criteria: (1) biopsy confirmation of the presence of a duplication of
the glomerular basement membrane on periodic acid–Schiff or silver
stain, and (2) 1 year of follow-up after the diagnosis. An electron
microscopic evaluation was performed to exclude membrane
duplication that was caused by recurrent or de novo glomerular
disease. The TG severity was scored using the Banff 97 classification
according to the percentage of involved glomerular peripheral
capillaries. This group was compared with a group of IF/TA patients
who were diagnosed within the same time period. The inclusion
criteria for the IF/TA group were as follows: (1) biopsy-confirmed
IF/TA; (2) the absence of accompaniment with acute/chronic
rejection or obvious calcineurin inhibitor toxicity; (3) the absence
of C4d staining by immunofluorescence; and (4) 1 year of follow-up
post biopsy. These patients were randomly matched with a group of
recipients with stable graft function who received protocol biopsies
as controls. Proteinuria is defined as urine protein over 0.4 g per day
measured in 24-h collections by colorimetric methods. Informed
consent was obtained from all patients, and the Human Subjects
Committee of Jinling Hospital, Nanjing University School of
Medicine approved all of the study protocols.
Renal biopsies
Protocol biopsies were performed at 2 weeks post transplantation,
and diagnostic biopsies were performed when serum creatinine
levels increased. Two needle biopsy cores were obtained from each
renal allograft for morphological study; one was used for formalin
fixation, and the other was used for quick-freezing. Hematoxylin
and eosin, periodic acid Schiff, methenamine-silver, and Masson’s
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Figure 3 |Capillary dilation in transplant glomerulopathy (TG). CD31 and CD68 co-staining showed glomerular capillary (GC) loop
dilation (a) and peritubular capillary (PTC) dilation (b) in the TG group, compared with GC (c) and PTC (d) staining in interstitial fibrosis/tubular
atrophy (IF/TA) group. (e) PTC density among the three groups revealed a rarefaction of PTCs in the IF/TA group. (f) Capillary diameters
among the three groups revealed significant PTC dilation in the TG group. (g) PTC diameter was strongly correlated with intracapillary
CD68þ cell infiltration in the TG group. (h) Glomerulus volume among the three groups revealed significant glomerulus enlargement in the
TG group. (i) GC loop diameters among the three groups revealed significant GC dilation in the TG group. (j) The diameter of the GC loop was
strongly correlated with intraglomerular CD68þ cell infiltration in the TG group. Original magnification,  400. SG, stable graft.
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trichrome stains were routinely performed on the formalin-fixed
tissues. The residual biopsy tissues were stored for future use. Fresh-
frozen tissues were analyzed by immunofluorescence microscopy
using a conventional panel of antibodies against IgG, IgM, IgA, C3,
C4, C1q, and C4d. C4d staining was routinely performed on frozen
slides using an indirect immunofluorescence technique with a
primary affinity-purified monoclonal antibody (mouse anti-human;
Quidel, San Diego, CA) and an FITC-labeled affinity-purified
secondary rabbit anti-mouse IgG antibody (Dako, Glostrup, Denmark).
The staining was performed using standard procedures.30 Positive
C4d staining was defined as a bright linear stain along the capillary
basement membranes that involved over half of the sampled
capillaries in accordance with the 2001 Banff Meeting.29
Immunohistological analysis
CD4, CD8, CD68, and CD20 were regularly detected when a biopsy
was performed. The intragraft expression of T-bet and GATA3 was
retrospectively studied via immunohistochemistry using stored
residual biopsy tissues. Immunohistochemistry was performed on
formalin-fixed, paraffin-embedded tissues. The antibody regimens
were conducted as follows: mouse monoclonal antibody against
T-bet (Santa Cruz Biotechnology, Santa Cruz, CA); rabbit polyclonal
antibody against GATA3 (Abcam, Cambridge, UK); and mouse
monoclonal antibodies against CD4 (Novocastra, Newcastle upon
Tyne, UK), CD8 (Novocastra), CD68 (Dako, Carpinteria, CA),
CD20 (Dako), and CD31 (Dako). The sections were reviewed by two
pathologists, and the results are expressed as the total number of
positive cells per glomerulus or per square millimeter in the cortex.
Microvascular and intracapillary cell counting
CD31 staining (which is specific for endothelial cells) was performed
to label the PTCs. After staining for CD31, the density and size of
the PTCs were calculated for each sample. The PTC density was
calculated by counting the total number of PTCs within the confines
of each of 10 random 0.25-mm2 fields (each of these fields was
delineated by a 1-cm2 ocular grid that was viewed at  400
magnification), and the result is expressed as the mean per field. The
diameter of these PTCs was also measured, and their mean was
calculated in micrometers. In addition, the cortex PTC spaces were
traced using the image analysis software program Image-Pro Plus
(Media Cybernetics, Silver Spring, MD). The intra-PTC area is
expressed as the proportion of total PTC spaces over the entire cortex
field. Intraglomerular capillaries were measured for their quantity
(capillary counts per glomerulus) and diameter on cross-section of
the glomeruli. To calculate the intracapillary inflammation cells, co-
staining of CD31 and inflammation markers (e.g., CD4, CD8, CD68,
and T-bet) were performed, and the results are expressed as the mean
per PTC or glomerulus. Glomerular cross-sectional area was also
determined using the Image-Pro Plus software.
Statistical methods
All data were analyzed using the Stata software (version 9.0).
Categorical variables were compared using Fisher’s exact test. Ordered
categorical data were presented as median (25th–75th percentiles) and
compared using the Kruskal–Wallis test. Continuous variables were
presented as mean±s.d. and compared using one-way analysis of
variance, or analyzed using nonparametric method if the data were
not normally distributed. Pairwise comparisons for categorical data
were performed using Fisher’s exact test; for continuous data, pairwise
comparisons were performed using Student’s t-test or Welch’s t-test;
and pairwise comparisons for ordinal categorical data were performed
using Wilcoxon rank-sum test. All P values were adjusted by
Bonferroni correction. Correlations between T-bet expression and
CD4þ , CD8þ , and CD68þ cells were evaluated by Spearman’s
correlation analysis. The level of statistical significance was set at
Pp0.05 (two-sided).
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